Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in MTVA — MetaVia Inc.

CIK 1214717 BOSTON, MA
Back to MTVA Full portfolio

Position in MTVA

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$30,478
-$9,883 QoQ
Shares Held
21,314
-36.6% QoQ
Ownership
0.324%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4
of 17 holders
Holding Since
Dec 2023
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MTVA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,427,018 across 520 Biotechnology names. MTVA ranks #490 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in MTVA

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $30,478 21,314
2026-03-31 $40,361 33,635
2025-09-30 $66,118 70,339
2025-06-30 $23,065 35,872
2025-03-31 $62,192 40,385
2024-12-31 $75,532 37,208
2024-09-30 $103,258 32,574
2024-06-30 $111,623 23,063
2024-03-31 $84,675 20,703
2023-12-31 $64,076 17,332